Philips Gets FDA Emergency Use Nod For Monitors, Displays During Covid-19 Pandemic
This Analyst Thinks Menlo (MNLO) Stock Is Poised for Growth
HCQ Misinformation Can Be Deadly: Let Patients Decide
Study finds COVID-19 convalescent plasma therapy safe, with 76% patients improving
From the research lab to your doctor's office – here's what happens in phase 1, 2, 3 drug trials
Aveo’s Tivozanib Gets FDA Nod For New Drug Application To Treat Kidney Cancer
Gilead Sinks 3% On New Remdesivir Data; Analysts Stay Sidelined
Solubilizer Captisol enables body to absorb authorized COVID-19 drug therapy
Quest’s Covid-19 Self-Collection Test Kit Gets FDA Nod For Emergency Use
Abiomed’s Heart Pump Gets FDA Emergency Use Status For Covid-19 Patients
FDA approval for Brilinta, EU recommendation for Lynparza
3 "Strong Buy" Biotech Stocks Under $5 With Major Catalysts Approaching
3 'Strong Buy' Biotech Stocks Under $5 That Could Go Boom
IPOs abound in the time of coronavirus, as Forma Therapeutics pencils in $150M Nasdaq debut
Eli Lilly’s Taltz Injection Gets FDA Nod For Inflammatory Spine Arthritis Treatment
Minerva Shares Tank 72% As Schizophrenia Drug Misses Trial Goals
Hydroxychloroquine combination risky for cancer patients with COVID-19: study
3 "Strong Buy" Penny Stocks That Offer Massive Potential Gains
PhaseBio Explodes 82% After-Hours On FDA Nod For Covid-19 Clinical Trial
3 “Strong Buy” Biotech Stocks Under $5 With Explosive Upside Potential
Fate Therapeutics (FATE) Cleared By FDA of IND Application for FT538
Agilent Up 5% On Solid Revenue Beat, But Top Analysts Stay Cautious
Gilead’s Remdesivir Most ‘Beneficial’ In Covid-19 Patients Who Need Extra Oxygen, Study Shows
Inovio Can Climb Higher, Says Top Analyst
Amarin Down 10% in Pre-Market On Generic Approval
3 "Strong Buy" Biotech Stocks Under $5 With Massive Upside Potential
Airway Therapeutics, Celonic Group partner to produce AT-100 as candidate for coronavirus
AstraZeneca Can Make Up To 1B Covid-19 Vaccine Doses, Signs First Supply Pacts
Mammoth Biosciences teams with GSK to put Covid-19 CRISPR tests at home, airports, borders
Gilead Still Holds the Winning Hand, Says 5-Star Analyst